Register today for the Womxn, Wellness & Cannabis Conference

Toronto, May 20, 2020 (GLOBE NEWSWIRE) — Marigold PR is proud to announce the conference agenda for its highly anticipated free global Womxn, Wellness and Cannabis Conference (WWC Conference) on Wednesday, May 27, 2020, at 8:30 a.m. EST. The WWC Conference is a unique opportunity for cannabis professionals to connect and engage with a global network of over 40 industry experts from the U.S., Canada, Switzerland, the U.K., and more.

The one-day event focuses on the feminine cannabis experience while providing access to valuable market insights, professional networking, collaboration and learning opportunities. Those interested in attending the WWC Conference are encouraged to register online as space is limited.

Participants will have exclusive access to informative seminars on relevant industry topics, including womxn in leadership, cultivation, diversity, patient insights, compliant marketing, and more. Speakers include Susan Chapelle, Trina Fraser, Lisa Harun, Rosy Mondin, Jamie Pearson, Tracy Ryan, and Ulla Haaning Singapuri. A complete list of speakers and topics is available on the WWC Conference website.

“This year, the WWC Conference is a free event, bringing the global community together to move their business forward during a challenging time,” says Katie Pringle, co-founder of Marigold PR. “We encourage the cannabis industry to join us to network, connect and learn from top industry experts.”

The WWC Conference is pleased to have over 20 event partners; media partners include Detonate Cannabis Agency, Grow Opportunity, CFN Media Group, CannabisNewsWire, Cannabis Prospect Magazine, The Rise, Canndora, The Cannabis Marketer and The Her(B) Life. Community partners include Prohibition Partners Live, Shatterizer, Cori, Weed Mama, CanWeedine, Grow Sisters, Kelsey Cannabis, Mimi Cannabis, Alpha Woman, entOURage Network, Mothers Mary, Cannabis Retailer, Kantoka, Root Creative, SheCann, Cannabis Canada Buzz and Symposia. Opportunities are still available for media and community partners.

Register now for the free WWC Conference at https://wwcconference.com/. To view the conference agenda, click here.

Follow the #WWCConference on Twitter and Instagram for the latest updates.

For more media inquiries or more information contact Danielle McKay, Marketing & Media Coordinator at [email protected].

About Marigold Marketing & PR

Marigold Marketing & PR is an award-winning marketing and PR firm for licensed producers and national brands. Marigold offers full-service packages to clients that include branding, social media, PR and publicity and integrated marketing. Marigold creates results-driven marketing campaigns of all sizes, leveraging paid, owned and earned media. Marigold makes an impact for clients through awareness-building campaigns, industry focus and excellent service. Learn more about Marigold’s all-encompassing services here.

• WWC Conference – PR #3 Graphic (1)

Danielle McKay Marigold Marketing & PR 9058087230 [email protected]

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Cannabidiol, better known as CBD, has become one of the most popular wellness products in the United States over the past couple of years. BDS Analytics and Arcview Market Research expect CBD sales to grow at a 49% compound annual growth rate to surpass $20 billion by 2024—making up about half of the total cannabinoid industry—as sales shift from cannabis dispensaries to pharmacy and grocery stores.

CaniBrands brings extensive consumer packaged goods and branding experience to the CBD space, where it has developed a science-based product line encompassing numerous form factors and proprietary formulations. The company’s Can-i products are supported by 12-time Olympic medalist Dara Torres—its Global Spokesperson—and acclaimed high-performance trainer, Andy O’Brien—its Sports Science Advisor.

In a recent interview with CFN Media, Co-Founder and CEO Chris Lords discusses the company’s unique approach to the market and growing product line:

Are you an accredited investor? Learn how to invest in CaniBrands before it goes public

Holistic Approach with Many Choices

CaniBrands offers a premium product line that includes Can-i Boost, Can-i Sleep, Can-i Mend and Can-i Fresh, which are scientifically-formulated to deliver specific wellness benefits.

The company’s best-seller by revenue, Can-i Boost, combines hemp-derived CBD with a powerful blend of vitamins and herbal extracts designed to keep you alert, energized and clear-headed without any crashes or jitters. Meanwhile, the company’s best-seller by volume, Can-i Sleep, combines the same hemp-derived CBD with melatonin and other supplements designed to promote a healthy sleep cycle.

In addition to these best-selling products, the company’s Can-i Mend addresses pain, inflammation and soreness by accelerating the body’s healing process. The product is popular among athletes looking to cut recovery time and reduce post-workout soreness. And finally, the company’s Can-i Fresh is designed to deliver antioxidants, support the immune system and promote mental clarity on a day-to-day basis.

These products are available in multiple form factors, including a sublingual tincture, oral spray and cream, providing customers with many different choices. For example, many athletes appreciate creams to provide localized pain relief, whereas oral sprays provide a convenient on-the-go form factor for busy people. All of these products can be helpful at different times of the day from Can-i Boost in the morning to Can-i Sleep at night.

Are you an accredited investor? Learn how to invest in CaniBrands before it goes public 

Active Expansion into New Markets

CaniBrands has been actively focused on establishing new distribution channels, expanding into new markets and launch new product lines.

The company began by building their own direct-to-consumer platform before moving onto Amazon Prime to access more households. Pilot programs are exploring the possibility of home delivery reselling in local markets, as well as online affiliate marketing, which could significantly expand its distribution and reach new customers throughout the United States that may not otherwise find them online.

Early next year, the company plans to launch its products in Canada before expanding into other international markets. The company’s Brand Ambassador, former NHL player and media personality Paul Bissonnette, will be integral in supporting the Canadian launch. Since becoming the first country to legalize recreational cannabis, Canada has been widely considered a leading market for cannabinoid-based products.

The company also aims to launch a variety of new product lines over time. For example, the company is exploring softgels, beverage, and other product formats (e.g. topicals, bars, and powders), as well as products containing other cannabinoids (e.g. CBN or CBG). The company’s CaniBuy ecommerce management platform also aims to integrate websites, ecommerce, payments and fulfillment into a single client-facing portal.

Gearing Up to Go Public in the Near-term

CaniBrands recently began a $5 million capital raise targeting accredited investors, and the founders and two strategic investors have already committed more than $1 million of the funding round. Management says that the proceeds will be put towards a variety of revenue-driving activities, as well as R&D and general operational expenses.

With no long-term debt, a seasoned management team, commercial products and a solid business model, the company is well-positioned to capitalize on the rapid growth of the CBD market over the coming years.

Accredited investors that are interested in participating in the funding round are encouraged to sign up to receive an investor presentation and corporate updates.

Are you an accredited investor? Learn how to invest in CaniBrands before it goes public

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://www.cannabisfn.com (the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

The Benzinga Cannabis Capital Conference will take place at Chicago’s Palmer House on October 22 and 23, 2019. Cannabis investors will have a chance to come face-to-face with cannabis companies to hear about their advancements in the rapidly growing industry, while cannabis executives will have an opportunity to grow their business and attract investors with lightning round presentations and one-on-one meetings.

The conference will feature speakers including:

CFN Media Interviewing Mark Krytiuk, President of Nabis Holdings at the Toronto Benzinga Capital Conference 2019

CFN Media will provide full coverage of the conference via exclusive interviews with thought leaders and pioneering companies. If you’re company is interested in an interview, please contact Frank Lane at [email protected] or (800) 517-5820 to schedule a time. The coverage will be published on the CFN Media Video Library over the coming weeks.

About the Benzinga Cannabis Capital Conference

The Benzinga Cannabis Capital Conference is the premier gathering of cannabis entrepreneurs and investors in North America. No other conference offers the level of access and seamlessness of interaction between entrepreneurs building future billion-dollar cannabis enterprises and the investors whose capital will make that happen. 

Individuals or companies interested in attending the conference can buy tickets online at:

https://benzingacannabisconference.com/chicago/ 

About CFN Media

See other upcoming conferences on CannabisFN.com’s conference calendar:

https://www.cannabisfn.com/event-calendar/

Click Here to Receive CFN Media’s Newsletter Every Week in Your Inbox

For Visitors and Viewers 

CFN Media’s Cannabis Financial Network (CannabisFN.com) is the destination for savvy investors and business people profiting from the worldwide cannabis industry. Viewers will see breaking news, exclusive content and original programming involving the people, companies and investments shaping the industry.

For Cannabis Businesses & Companies 

CFN Media is a leading agency and financial media network dedicated to the cannabis industry. We help private, pre-public and public cannabis companies in the US and Canada attract capital, investors and media attention.

Our powerful digital media and distribution platform conveys a company’s message and value proposition directly to accredited and retail investors and national media active in the North American cannabis markets.

Since 2013, CFN Media has enabled the world’s preeminent cannabis companies to thrive in the capital and public markets.

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://www.cannabisfn.com(the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

In a cannabis market forecast by Grand View Research to reach $66.3 billion by the end of 2025, companies of all sizes are elbowing each other for market share. At Sublime Canna, the model is to avoid the scrum, instead building a moat around a portfolio of products that ride the line between mass appeal and novelty.

As explained” by Sublime Canna CEO Alex Fang to CFN Media’s Greg Hasty at the recent NCIA CannaVest Conference, the company internally refers to its strategy as “USB,” an acronym for “Unique, Superior and Barrier to Entry.”

Sublime Canna CEO Alex Fang at the NCIA CannaVest Conference Speaking with CFN Media

Dosies, Ice Pops and Fuzzies

If there is one overarching theme regarding Sublime’s R&D view, it is “difficult is better.” This touches on all three components of the company’s USB mantra. For instance, take Sublime’s choice to manufacture a Tic Tac-like cannabis product. The decision came after market research showing that the orange Tic Tac is the best selling mint in North America.  

Accredited Investor? Click Here to Learn how to Invest in Sublime Canna

The problem was, in the words of Fang, a sugar panned mint is a “pain in the ass” to make. The manufacturing process is “artisan in many ways,” according to Fang and held extremely close to the vest by its owner.

It took a couple years and more money than was expected, but Sublime did it, developing a cannabis version of the mint that has been branded “Dosies.” Sublime is also making the “Miracle Mint” in blue raspberry flavor.

Sublime Canna’s Dosies sugar panned mint available in Cara Cara Orange & new flavor Blue Raspberry

When it came to an investment to penetrate the beverage segment, Sublime again got outside the box. Fang explained that while other companies were looking at sparkling or flavored water, Sublime management saw an opportunity to “take the vacuum in the marketplace” when California outlawed frozen confection. 

While peers were seeing their cannabis ice cream, frozen yogurt and popsicles removed from shelves, Sublime was developing a shelf stable, fully California-compliant product “Sublime Ice Pops”

Again, it was market research and innovative thinking that underscored product development after leadership realized that ice pops are frequently recommended for people getting out of chemotherapy.

Sublime Canna’s Infused Medicated Ice Pops

The company didn’t back down from the challenge of developing a unique infused pre-roll either. Sublime’s “Fuzzies” pre-rolls contain a proprietary list of ingredients including premium flower, in a recipe that creates a “very involved, complicated product that is completely different from what is the norm.”

The result? The best selling infused pre-roll in California, trumpeted Fang.

Accredited Investor? Click Here to Learn how to Invest in Sublime Canna

A Commitment to Differentiation

Fang explained during the discussion that it never made sense to him to spend resources on developing products that would compete head-to-head with already established products, even if he thought they could make something better. Simply, there are already plenty of “pretty good” gummies out there, so why waste resources making another?

For Sublime, the smart money goes into investing in differentiation and the technology and moats associated with it that keep any potential competition at arm’s length because making competing products is extremely difficult.

“We believe that by investing the time, effort and energy that we have over the past two years in all of the different formats that we have developed – as expensive as it has been – ten years down the road in retrospect when we’re making everything for a few pennies a unit because we’ve gone through this ‘manufacturing hell’ that it will be money well spent,” said Fang.

Apparently, the innovation is resonating with the investment community as gauged by  Sublime recently closed a $20 million capital raise. A portion of the funds has been earmarked for completion of products in the portfolio. Elsewhere the company is working on new product development, which is being spearheaded by L.J. Buffardi, who came on as VP of Edibles Development at Sublime subsequent to the sale of his family business, Ferrara Candy to Nutella and Tic Tac maker Ferraro for $1.3 billion in 2018.

“There is some really exciting stuff that only exists in industrial candy that we are going to bring over to [the cannabis] industry,” Fang said referencing Buffardi’s skill set, adding, “It’s super exciting” with a big grin.

Accredited Investor? Click Here to Learn how to Invest in Sublime Canna

Fang further detailed that the company will remain focused on the upper echelon in the cannabis space. “We’re not the type of company that is going to make a B+ topical or a B+ edible and dump A+ marketing behind it. All of [our products] have the ability to scale and the ability to have mass appeal. If we’re doing this the right way, we can invest in making a moat and then we can run; we can go and scale from there,” he said of the upcoming growth plans.

When it comes right down to it, Sublime proves that something as small as a Tic Tac can make it easily understandable about the appeal and potential for a business model underpinned by a quest for differentiated products with mass appeal.

To Learn More About Sublime Canna Please Visit Their Website @https://www.sublimecanna.com

Accredited Investor? Click Here to Learn how to Invest in Sublime Canna

Click Here to Receive CFN Media’s Newsletter Every Week in Your Inbox

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://www.cannabisfn.com(the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.

About Ash Stringer

As an emerging and relatively new line of business, cannabis has already proven itself to be a powerhouse of a market. The global cannabis industry’s revenue ballooned to US $12.2 billion in 2018, with predictions that it will reach $16.9 billion in 2019, according to BDS Analytics.

The burgeoning industry is setting trends in many ways, not the least of which is the role that women are playing across the cannabis landscape. A new report by Vangst surveyed 166 cannabis companies in the US, and found that women represent 38.5% of the employees, a much higher proportion than in other industries, such as tech, construction, and beverage and tobacco.

Of these women, 17.6% held the role of ‘Director’ or ‘Executive.’ 43% of all companies who took part in the survey had a majority of female employees, with seven of these companies being comprised of all-women teams.

For a new industry, this is an exciting trend. Having diversified leadership gives strength to any team, a fact that is illustrated by the culture at The Yield Growth Corp. (CNSX: BOSS) (OTCQB:BOSQF) (Frankfurt:YG3). Headed by CEO Penny Green and a strong team of women leaders, this fresh and innovative company has already had great success in the cannabis industry and, with the continued collaboration of this team of executives, the future looks bright.

Click here to receive an investor deck and corporate updates

Leaders With Proven Expertise

With over two decades experience building companies, Penny Green is now the Director, President and CEO of The Yield Growth Corp. and CEO of Urban Juve. She has worked in many industries, ranging from music to pharmaceuticals, law to blockchain technology.

Her dossier of public successes is impressive. She was recognised on PROFIT Magazine’s W100 of top Canadian entrepreneurs. Bacchus Law Corporation was in the PROFIT 500 Fastest Growing Companies in 2015 and 2016, when it was under her leadership as CEO. Penny also has substantial experience in capital markets, and has been involved in over 100 private to public companies.

Amy Frankel is another key component of this flourishing company. She is Vice President Licensing & General Counsel to The Yield Growth Corp., and has over 15 years experience in this role building and expanding international brands.

Amy was Co-General Counsel of Aritzia LP (TSX: ATZ). During her time there, annual revenues increased around 100%, jumping from $400 million to $743 million. Amy was also Associate General Counsel of Skechers USA Inc. (NYSE: SKX), where annual revenues increased by approximately 50%. She has expertise in negotiating licensing deals, forming intellectual property strategies and managing international intellectual property portfolios.

Another leader who has a history with Aritzia is Tamara Melck, Chief Operating Officer for The Yield Growth Corp. Tamara has extensive experience in scaling operations. She was a key component in the growth of Aritzia, where she was Vice President, Corporate Operations and Executive Vice President. When she left the company in 2017, it had reached a market capitalization of over US $1 billion. Tamara was also a member and former chair of the Executive Committee of Aritzia.

Click here to receive an investor deck and corporate updates

Urban Juve’s Impressive Line Up of Leaders

The Urban Juve line is built on ancient Indian Ayurvedic wisdom fused with advanced science, and the leaders at Yield Growth knew they would have to find someone with a commendable background in this discipline. This search led them to Bhavna Solecki.

With over 30 years of Ayurvedic practice, Bhavna is at the centre of Urban Juve’s new generation of products, and oversees its product research, development and production. In 2003, she launched Samadhi Mobile Services, where she led 25 Ayurvedic practitioners on high-profile contracts including George Michael and David Beckham, before developing Inner Evolution Healing Centre Ltd. in 2011 to teach and enable Ayurvedic practitioners.

In 2017, her lifelong experience in Ayurvedic techniques led to the foundation of Urban Juve, alongside Penny Green. As Ayurveda Senior Research Scientist, she ensures compliance with Health Canada regulations, develops educational literature for staff and customers, and incorporates new technology into the supply chain.

Click here to receive an investor deck and corporate updates

With Bhavna set to oversee the development of Urban Juve products, Yield Growth needed to appoint a President of Urban Juve with a background in the health and beauty industry. Enter Sandi Lesueur, who has designed and launched several product lines for physicians and celebrities, including dermatologist Dr. Jason Rivers and Oprah Winfrey’s makeup artist, Derrick Rutledge at OOH Lifestyle. During her eight year tenure, Sandi played a huge role in the astronomical rise of M.A.C Cosmetics, where she helped the company grow from 3 stores to 88 across Canada.

Sandi also served as CEO of Riversol Skin Care Solutions Inc. where she collaborated with the Vice President of the Dermatology Association of Canada, Dr. Jason Rivers, to develop the company, and founded the second line of Riversol MD.

Her knowledge of the health and wellness industry led her to Urban Juve, where she is now President and on track to position the company as a globally successful brand.

Impressive Public and Investor Relations

Krystal Pineo is the Director of The Yield Growth Corp. She has over eight years experience as an early stage investor and fundraiser for venture capital projects. Krystal founded KP Capital Inc, a family office that invests in early stage startups, and she is also the chief financial officer and director.

Krystal has an impressive global network within the cannabis industry, which led to Urban Juve being included in this year’s pre-Oscar event.

Working alongside Krystal is Kristina Pillon, head of Investor Relations. Kristina joined the Yield Growth Corp. in November 2018. She has an extensive background in public relations and marketing, and nearly 10 years experience in capital markets, where she focussed on small cap metals and mining in a number of roles, including investor relations, marketing, and institutional equity sales. She also has six years experience at Red Cloud Klondike Strike, where she worked in investor relations and institutional equity sales.

Click here to receive an investor deck and corporate updates

Women Set on Success

Yield Growth is a prime example of the refreshing trend toward diversity throughout the cannabis world. The company is driven by women from a multitude of backgrounds and disciplines, all successful in their own right, and all positioned to take the company to the next level. Keep an eye on this group of women as The Yield Growth Corp. continues to grow its product line and retail footprint across North America and internationally. They mean business, and business is good.

Click Here to Receive CFN Media’s Newsletter Every Week in Your Inbox

Disclaimer

CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://www.cannabisfn.com(the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies.  We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.

About Joy Crosby

The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (Frankfurt: YG3) is a company dedicated to disrupting the health and wellness industry, with its many subsidiaries offering both CBD and THC infused products. By targeting specific niches of the cannabis industry, the company has seen great success both in the US and Canada. Now they turn their focus to aggressively targeting the European market.

Entering the Industry Early on

The European cannabis market is still in its infancy. The availability of cannabis-based products is limited, as is consumer awareness, and this offers enormous opportunity for developed brands to enter and dominate this industry.

Brightfield Group, a leading market intelligence firm for the cannabis industry, has estimated in their recent report that the European CBD market will see incredible growth over the next four years. In 2018 the market was estimated to be at US $318 million, and is expected to grow 400 percent through 2023.

Click here to receive an investor deck and corporate updates

This is an ideal market for the Yield Growth to target. Using their success in the US and Canada as a blueprint, they anticipate that the European market will offer them opportunity for serious growth. ‘We intend to generate significant sales revenue by aligning ourselves with different distributors that have strong networks in diverse regions,’ said Penny Green, CEO of Yield Growth.

Definitive Agreement Announced

Never one to delay, Yield Growth announced on July 10 that they have entered into a definitive agreement with Melorganics Hellas for distribution of Urban Juve products in Greece and Cyprus.

Melorganics Hellas intends to enter the Greek and Cypriot markets with a full line of CBD products. With their plan to building strategic alliances with companies that focus on the development of unique health products that utilise cannabis and botanical oils, they are the ideal candidate to distribute Urban Juve’s Ayurvedic products.

Melorganics will act as the exclusive distributor and non-exclusive e-commerce distributor for Urban Juve products. Per the agreement, the must purchase a minimum amount of Urban Juve products of US $300,000 in the first year and $500,000 in the following years to maintain exclusivity.

This agreement will ensure Yield Growth has significant presence in this market, which marks them as a key contender in the European cannabis industry. Greece legalised cannabis for medical reasons in 2018, and has since enjoyed an upsurge of foreign and local investment.

Urban Juve recently announced it had received a Compliance Certificate for sale of its first product in the European Union, and has plans to register an additional ten products in upcoming months.

Marketing efforts in Europe will begin in the fall, and will include a product feature in the September issue of British Vogue.

Click here to receive an investor deck and corporate updates

Negotiations Underway with Other Distributors

Not one to move slowly, Yield Growth is already in negotiations with distributors for France, Poland, Turkey and the United Kingdom, the latter of which is the largest CBD market in the EU, with projections that it will grow to GB £16.5 billion in the next decade. There are also upcoming meetings set to discuss expansion in South America, Germany and Portugal.

Positioned for Global Success

Yield Growth has proved itself as a dominant business within the crossover market of cannabis products and the wellness industry. Its early success in the US and Canada have marked it as an established brand. With its quick response to developing legislation in the European Union, it has positioned itself to be a leading company as laws in the EU allow the legal cannabis industry to grow. Between its success in North American and its strong alliances with European distributors, Yield Growth has put the wheels in motion to achieve global success.

Click here to receive an investor deck and corporate updates

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

The last six weeks have seen major strides taken by The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF) (Frankfurt:YG3) to maintain their position as an exciting, forward-thinking and innovative cannabis company. An organisation dedicated to disrupting the wellness industry with revolutionary cannabis and hemp-based products, Yield Growth continues to make advances; it has released new products, continued to build and strengthen strategic alliances, and even begun to tackle the global market.

Wright & Well Enters Colorado’s Legal Cannabis Industry

Wright & Well, a subsidiary of Yield Growth, is a bold brand that aims to help relieve pain and anxiety through their line of THC and CBD based oils, gels, balms and other topicals.

On June 20th, the Oregon Liquor Control Commission (OLCC) gave final packaging approval for an additional three cannabis products to be distributed in Oregon. With this in place, Wright & Well will now begin manufacturing on all nine of their products.

According to Statista, legal sales of cannabis in the state of Oregon alone are projected to exceed US $1 billion by 2023, making this a major market to tackle, and an ideal blueprint for the brand as other jurisdictions across the country legalise the sale of cannabis and cannabis based products. Wright & Well jumped into the market early on, and are likely to be an important part of the Yield Growth roster as cannabis trends develop across the country.

Click here to receive an investor deck and corporate updates

Urban Juve Maintains Notable Position in the Beauty World

Urban Juve is Yield Growth’s flagship brand, which blends ancient Ayurvedic knowledge with cutting edge science and technology to produce a proprietary skincare and wellness line of products, all of which are infused with hemp root and seed oil.

The company recently announced an alliance with beauty giant ipsy, the world’s leading beauty commerce community with over three million monthly members. Part of the alliance included the sale of Urban Juve products on Shopper, ipsy’s exclusive commerce marketplace, and Yield Growth has announced that this is now live.

With the global wellness market worth US $4.2 trillion according to the Global Wellness Institute, analysts now predict that CBD infused products will be a huge part of the industry, with Hemp Industry Daily projecting that within the US, this niche will grow to US $7 billion by 2023. Between their strategic alliances and wide-reaching marketing campaign, Urban Juve has positioned itself to be at the forefront of this new market.

Continuing to Meet Consumer Demands

Urban Juve has seen such positive responses from customers that on July 5th they announced the launch of three new Hemp Daily Ritual Kits, that feature the brand’s most loved products in a curated package.

The kits were launched partly in response to consumer’s who love the products and want to share them with others. ‘Whether personal gifts or professional-volume gifting, our new offering is just what customers are looking for, and our strategic focus on the gift-giving customer helps to generate additional revenue for the brand,” says Sandi Lesueur, president of Urban Juve.

The company continues to identify ways in which to reach new customers, while also maintaining a dedication to their existing customer base.

Click here to receive an investor deck and corporate updates

Identifying Opportunities for Greater Revenue

Off the success of their existing brands, Yield Growth has invested time and money into the research and production of additional products. On June 25th, the company announced that it has completed testing on nine new products. The products contain hemp and other botanicals and have passed stability and preservation challenge tests at a laboratory in British Columbia.

The nine products include eye cream, deodorant, facial cleansers, facial oils and face masks. All the formulas in Yield Growth’s products are produced with the highest quality essential oils and pure botanical extracts. And in response to growing consumer trends, the company maintains a dedication to cruelty free practices.

With Jefferies financial research group’s estimation that the CBD Beauty Market will reach US $25 billion in ten years and amass 15% of the total skincare industry, Yield Growth is wise to continue to invest in this segment. With plans to launch several brands in California within the next 4 months, Yield Growth continues to prove itself as a force to be reckoned with in the wellness and CBD crossover market.

Going Global: Agreements Underway in Europe

In one of its most exciting reveals, Yield Growth announced on July 2nd that its Urban Juve Anti-Ageing Serum can now be sold in the European market. A Compliance Certificate was issued by Biorius, who is acting as Urban Juve’s Responsible Person in Europe.

Yield Growth had previously signed a letter of intent with Melorganics Hellas, who will act as the exclusive retail distributor and non-exclusive e-commerce distributor for the company’s flagship brand’s products in Cyprus and Greece.

As the European Union continues to create legislation that will bring cannabis closer to the mainstream market, luxury cannabis products such as Urban Juve’s line are becoming increasingly popular. With a population of well over 500 million, the EU offers an enormous market opportunity. Urban Juve hopes to obtain Compliance Certificates for all 11 of its products in the EU, and sales of its products are expected to begin in the fall of this year.

Click here to receive an investor deck and corporate updates

Positioned to be a Leader as the Industry Develops

Yield Growth is a savvy company which manages to keep its many subsidiaries developing and growing alongside the growth of the industry. It is apt at identifying profitable market opportunities and it seizes these boldly and quickly. This, coupled with the company’s many strategic alliances has positioned Yield Growth to be a leader in the crossover market of cannabis based beauty products, both in North America and globally.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

 Jushi Holdings Inc. (NEO: JUSH) made its public debut on Monday, June 10^th.  The Boca Raton-based company has assembled a highly skilled and diversified team that is moving with a purpose, building a global footprint via organic and inorganic growth to capitalize on booming demand for cannabidiol, or CBD, in North America and abroad.

According to Cowen Equity Research and Marijuana Business Daily, global legal cannabis sales are forecasted to climb from about $9.6 billion in 2017 to $75 billion in 2030. In our opinion, there is no better time to be invested in this burgeoning industry.

Additionally, CBD is a non-psychotropic molecule found in cannabis and hemp.  The US Farm Bill, passed in December 2018, allowed, states to legalize industrial hemp and CBD products within their state paving the way for interstate commerce, while setting off a race to develop new products from hemp-derived CBD.

According to a report by market analysts at the Brightfield Group published in September 2018, hemp-based CBD is expected to blossom from around $600 million in 2018 to $22 billion by 2022.

Please click here to receive an investor deck and corporate updates

Operations Across the United States

Jushi and its portfolio companies have hemp operations in New York and are in the process of securing cannabis operations in California, New York, Virginia, Pennsylvania, Ohio, and Nevada as well as additional states.  The targets in California, the biggest cannabis market in North America, include several handpicked retail cannabis locations with delivery capabilities and licenses for distribution, cultivation and processing.

In the East, Jushi is emerging as a leading player through its acquisition of Mend Products, formation of its hemp-centric subsidiary, Sound Wellness Holdings, Inc. earlier this year, and its relationship with the DENT Neurologic Institute in Buffalo, NY.

Quality is a differentiator for Jushi. All Jushi products are tested by an independent third party to ensure consistency for its premium goods, which cover the full spectrum, including oils, soft gel caps, creams, tinctures and more.  Most products on the market today do not go through any independent testing to ensure consistency across batches, safety and quality, or even CBD levels.

Meanwhile, the company’s subsidiary Sound Wellness, LLC, which earned a hemp processing license through NY’s Industrial Hemp Agricultural Research program, is moving forward with its own hemp/CBD manufacturing facility in upstate New York.  When completed, Sound Wellness will have one of the largest industrial hemp processing, extraction and manufacturing operations in the Northeastern United States.

Please click here to receive an investor deck and corporate updates

Scientific Commitment to Health and Wellness

Coupled with savvy acquisitions, partnerships and key hires, Jushi has access to private research thanks in part to Jushi’s Medical Director, Dr. Laszlo Mechtler, and Jushi’s Medical President, Steven Przybyla.  Dr. Mechtler, a world-renowned expert in cannabis and cannabis research, was a founder of Mend and still serves as Medical Director at the DENT Neurologic Institute, operator of the largest medical cannabis program in New York.

With Dr. Mechtler’s oversight, the full-spectrum CBD-hemp derived products of Mend are formulated using patient data collected from thousands of patients and formulated by board-certified physicians with a dynamic process for revisions based upon new data.  Dent’s large pool of patient data indicates substantial benefits from cannabis-derived products.  Further, Dent and Mend are in the process of initiating groundbreaking research through two planned clinical studies into the impact of Mend products.

Prior to taking on the role of President of Jushi Medical, Steven Przybyla worked as EVP of Business Development, General Counsel and Director of Cannabis Programs at DENT, strengthening the ties between Jushi and the prestigious institution.

The Mend Store held its grand opening in Dent Tower in Buffalo on June 3, 2019. While open to public, the Mend Store also expects to serve patients of DENT’s medical cannabis program. Sales have started strong and are exceeding internal estimates.

Other initiatives of the company include international expansion by Jushi Europe, which will be focused on an early stage market through a separately financed entity.

Elsewhere, Jushi recently acquired the trademarks The Clinic^TM, The Clinic Consulting Services^TM, The Bank^TM and The Lab^TM as well as, subject to certain limited exceptions, intellectual property derived from the operations of The Clinic^TM Colorado. The Clinic Colorado, a Denver-based cannabis company, is known for its intellectual property concerning cannabis cultivation, processing, retail distribution, compliance, and safety in multiple states, and has received more industry awards than any other cannabis company in the US with 32 first place awards. The Clinic Colorado has had a track record of success with The Bank^TM owning intellectual property to cultivation and genetics of over 150 different strains and the Lab’s^TM intellectual property consisting of proprietary concentrates and extraction techniques. This sophisticated IP will complement Jushi’s expanding platform.

Please click here to receive an investor deck and corporate updates

The Upshot

Piloted by Deutsche Bank corporate finance veteran Erich Mauff (Founder, President, Board Member) and experienced hedge fund manager Jim Cacioppo (Founder, CEO, Chairman of the Board), Jushi combines public company and capital markets know-how with an excellent mix of cannabis and medical executives to create a multi-state operator with a commitment to shareholder value and highest quality products.

These fundamentals underpin management and advisors investing more than $20 million of the approximately $135 million that Jushi raised since February 2018 to support growth through its diverse capital allocation methodology. With Jushi recently going public on Monday, June 10th, keep an eye on further developments as the company executes its vision of becoming a bold, new, principled leader in the cannabis and hemp industry.

Please click here to receive an investor deck and corporate updates

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.